A Food Effect Study of SPH5030 Tablets.

Clinical trial NCT06372223 · COMPLETED

Trial details

NCT number: NCT06372223
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-03-04
Primary completion: 2024-03-25
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.